As a venture capital company, HBM BioVentures is invested globally in some 40 mature emerging companies in the biotechnology/human medicine, diagnostics and medical technology sectors. The primary products of HBM BioVentures` portfolio companies are either at an advanced stage of development or already available on the market. The company
focuses on unquoted emerging companies, with two-thirds are invested in private companies that offer high value creation potential. This has enabled HBM BioVentures to carve out a unique and distinctive market position. HBM BioVentures has a broad shareholder base and is listed on the SIX Swiss Exchange (ticker: HBMN).
Industries: Biotechnology
Health Care
Pharmaceutical
Therapeutics
Life Science
Genetics
Information Technology
Biopharma
Medical
Mobile Apps
Nursing and Residential Care
Location: Zug, Canton of Zug, Switzerland
